| 产品编号 | CFN60060 | |
| CAS编号 | 923564-51-6 | |
| 分子式 = 分子量 | C47H55ClF3N5O6S3 = 974.61 | |
| 产品纯度 | >=98% | |
| 物理属性 | Powder | |
| 化合物类型 | Alkaloids | |
| 植物来源 | ||
| ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用 | ||
| 产品名称 | 产品编号 | CAS编号 | 包装 | QQ客服 |
| 生根粉263 | CFN60060 | 923564-51-6 | 1mg | QQ客服:1457312923 |
| 生根粉263 | CFN60060 | 923564-51-6 | 5mg | QQ客服:1457312923 |
| 生根粉263 | CFN60060 | 923564-51-6 | 10mg | QQ客服:1457312923 |
| 生根粉263 | CFN60060 | 923564-51-6 | 20mg | QQ客服:1457312923 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)| Description: | Navitoclax (ABT-263) is a potent inhibitor of Bcl-xL, Bcl-2 and Bcl-w with Ki of ≤ 0.5 nM, ≤1 nM and ≤1 nM in cell-free assays, but binds more weakly to Mcl-1 and A1. | |||
| Targets: | Bcl-xL/Bcl-2/Bcl-w | |||
| In vitro: |
|
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.0261 mL | 5.1303 mL | 10.2605 mL | 20.521 mL | 25.6513 mL |
| 5 mM | 0.2052 mL | 1.0261 mL | 2.0521 mL | 4.1042 mL | 5.1303 mL |
| 10 mM | 0.1026 mL | 0.513 mL | 1.0261 mL | 2.0521 mL | 2.5651 mL |
| 50 mM | 0.0205 mL | 0.1026 mL | 0.2052 mL | 0.4104 mL | 0.513 mL |
| 100 mM | 0.0103 mL | 0.0513 mL | 0.1026 mL | 0.2052 mL | 0.2565 mL |
| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 6'-O-β-D-葡萄糖基龙胆苦苷; 6'-O-beta-D-Glucosylgentiopicroside | CFN90678 | 115713-06-9 | C22H30O14 = 518.47 | 20mg | QQ客服:2159513211 |
| Yamataimine; Yamataimine | CFN00352 | 67113-69-3 | C18H27NO5 = 337.41 | 5mg | QQ客服:2159513211 |
| Ampelopsin G; Ampelopsin G | CFN95148 | 151487-09-1 | C42H32O9 = 680.7 | 5mg | QQ客服:1413575084 |
| 木兰箭毒碱; Magnocurarine | CFN93230 | 6801-40-7 | C19H24NO3 = 314.4 | 20mg | QQ客服:3257982914 |